Insulin efsitora alfa (investigational once-weekly basal insulin): In another ADA-sponsored symposium, Lilly will share results from the QWINT-1, QWINT-3 and QWINT-4 Phase 3 trials, which evaluated ...

The study abstracts were published on the ASCO website on May 22, 2025 (CDT), with key highlights summarized below: ...

Data to be presented at ASCO reflect Boehringer's broad pipeline and growing body of evidence supporting innovative therapies for various cancersPatient-reported outcomes from the Beamion LUNG-1 study ...

Avalyn’s Phase 1a trial of AP02 assessed clinical tolerability and pharmacokinetic profiles in three SAD cohorts, up to a maximum 2.0 mg dose in HVs; two BAL cohorts in HVs; and one cohort of patients ...

“New real-world evidence underscores the growing burden of patients living with pulmonary sarcoidosis and the continued reliance on oral corticosteroids as the standard of care, despite their ...

A Nova Scotia woman recovering from a lung transplant says she had to take tens of thousands of dollars ... the East Coast were choosing palliative care instead of lung transplants because ...

Add movement to breathing to open up the chest and stimulate the lungs.Stand tall with feet hip-width apart. Inhale through your nose and raise both arms slowly over your head. Hold for 2 seconds ...

Around 49% of people across London and the UK suffer from hayfever. Fed chair calls out Trump’s Harvard attacks during bombshell Princeton speech Five living heirs of Leonardo da Vinci ...

LANCASTER, S.C., April 7, 2025 /PRNewswire/ -- Nutramax Laboratories Consumer Care, Inc. is pleased to share ... smokers that are at high-risk for lung cancer. These results significantly add ...

As you go through lung cancer treatment, you’ll have a whole team of professionals ensuring that you’re getting quality care. That group ... questions about how to take it and what side ...